These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9385394)

  • 1. Critical factors in assessing risk from exposure to nasal carcinogens.
    Bogdanffy MS; Mathison BH; Kuykendall JR; Harman AE
    Mutat Res; 1997 Oct; 380(1-2):125-41. PubMed ID: 9385394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of a hybrid computational fluid dynamics and physiologically based inhalation model for interspecies dosimetry extrapolation of acidic vapors in the upper airways.
    Frederick CB; Bush ML; Lomax LG; Black KA; Finch L; Kimbell JS; Morgan KT; Subramaniam RP; Morris JB; Ultman JS
    Toxicol Appl Pharmacol; 1998 Sep; 152(1):211-31. PubMed ID: 9772217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments.
    Butterworth BE; Conolly RB; Morgan KT
    Cancer Lett; 1995 Jun; 93(1):129-46. PubMed ID: 7600540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adjustment factor for mode-of-action uncertainty with dual-mode carcinogens: the case of naphthalene-induced nasal tumors in rats.
    Bogen KT
    Risk Anal; 2008 Aug; 28(4):1033-51. PubMed ID: 18564993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment.
    Morgan KT
    Toxicol Pathol; 1997; 25(3):291-307. PubMed ID: 9210261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode-of-action framework for evaluating the relevance of rodent forestomach tumors in cancer risk assessment.
    Proctor DM; Gatto NM; Hong SJ; Allamneni KP
    Toxicol Sci; 2007 Aug; 98(2):313-26. PubMed ID: 17426108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chloroform mode of action: implications for cancer risk assessment.
    Golden RJ; Holm SE; Robinson DE; Julkunen PH; Reese EA
    Regul Toxicol Pharmacol; 1997 Oct; 26(2):142-55. PubMed ID: 9356278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset.
    Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
    Toxicol Sci; 2004 Nov; 82(1):279-96. PubMed ID: 15254341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies dose extrapolation for inhaled dimethyl sulfate: a PBPK model-based analysis using nasal cavity N7-methylguanine adducts.
    Sarangapani R; Teeguarden JG; Gentry PR; Clewell HJ; Barton HA; Bogdanffy MS
    Inhal Toxicol; 2004 Aug; 16(9):593-605. PubMed ID: 16036752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human carcinogenic risk evaluation, part II: contributions of the EUROTOX specialty section for carcinogenesis.
    Bolt HM; Degen GH
    Toxicol Sci; 2004 Sep; 81(1):3-6. PubMed ID: 15159528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mode of action in relevance of rodent liver tumors to human cancer risk.
    Holsapple MP; Pitot HC; Cohen SM; Boobis AR; Klaunig JE; Pastoor T; Dellarco VL; Dragan YP
    Toxicol Sci; 2006 Jan; 89(1):51-6. PubMed ID: 16221960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of nasal tumors in rats exposed to hexamethylphosphoramide by inhalation.
    Lee KP; Trochimowicz HJ
    J Natl Cancer Inst; 1982 Jan; 68(1):157-71. PubMed ID: 6948124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
    Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
    Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic-induced carcinogenesis--oxidative stress as a possible mode of action and future research needs for more biologically based risk assessment.
    Kitchin KT; Conolly R
    Chem Res Toxicol; 2010 Feb; 23(2):327-35. PubMed ID: 20035570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25.
    Sanner T; Dybing E; Willems MI; Kroese ED
    Pharmacol Toxicol; 2001 Jun; 88(6):331-41. PubMed ID: 11453374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper respiratory tract surface areas and volumes of laboratory animals and humans: considerations for dosimetry models.
    Ménache MG; Hanna LM; Gross EA; Lou SR; Zinreich SJ; Leopold DA; Jarabek AM; Miller FJ
    J Toxicol Environ Health; 1997 Apr; 50(5):475-506. PubMed ID: 9140466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.